|Videos|January 11, 2021

New COVID-19 Variants: What Do They Mean?

More transmissible variants are emerging quickly. An expert explains why it's expected, but concerning.

As national and global coronavirus 2019 (COVID-19) cases continue to rise in early 2021, discussion around the pandemic virus has shifted to the emergence and tracking of differing variants, borne out of mutation.

The most significant of recently observed variants—the so-called B.1.1.7. variant, initially traced from southeast England—has spread internationally at a rapid pace. It is anticipated by experts that it is a much more transmissible form of the virus, and could eventually become the dominant variant in the world.

Though this news come as an alarm—and puts even greater stress on the rollout of available vaccine doses in the coming weeks—it’s nothing surprising to investigators.

In an interview with Contagion, Adam S. Lauring, MD, PhD, a professor in the Division of Infectious Diseases at the University of Michigan, and author of a recently published JAMA viewpoint on genetic SARS-CoV-2 variants, explained the newly discussed variants have been long-developing and essentially inevitable.

“We may see another variant become the dominant strain,” he said. “That’s a lot of what virus evolution is. It’s just something that we’re going to keep seeing, and the work for scientists is to figure which ones are concerning and why.”

Lauring also highlighted the B.1.1.7. variant, a result of numerous mutations which has allowed for greater transmissibility and the potential for the variant to become globally dominant.

Among the practices necessary to address the new COVID-19 threats are increased sequencing and an improvement of social distance strategies.

“It’s important to put the concern in the right place,” Lauring explained. “The more immediate concern is: if this virus is spreading more rapidly, then it’s going to be harder to control period, with our current practices.”


Related to this article

NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.
FAQ: Measles
With US measles cases nearing 3,900 this year and Pennsylvania reporting its fifth measles-related death, here is a review of how the virus spreads, how it is prevented and managed, and what severe disease looks like.
FAQ: Pneumonic Plague
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.